Charles Schwab Investment Management Inc. lessened its holdings in Cronos Group Inc. (NASDAQ:CRON – Free Report) by 2.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 374,590 shares of the company’s stock after selling 8,710 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Cronos Group were worth $829,000 at the end of the most recent quarter.
Several other institutional investors have also recently bought and sold shares of the business. ClariVest Asset Management LLC boosted its holdings in shares of Cronos Group by 2.8% during the 2nd quarter. ClariVest Asset Management LLC now owns 273,184 shares of the company’s stock valued at $637,000 after acquiring an additional 7,362 shares in the last quarter. National Bank of Canada FI boosted its stake in shares of Cronos Group by 1,094.4% during the second quarter. National Bank of Canada FI now owns 15,169 shares of the company’s stock valued at $35,000 after purchasing an additional 13,899 shares in the last quarter. Cedar Wealth Management LLC grew its holdings in shares of Cronos Group by 65.4% during the second quarter. Cedar Wealth Management LLC now owns 37,935 shares of the company’s stock worth $88,000 after purchasing an additional 15,000 shares during the last quarter. International Assets Investment Management LLC increased its stake in shares of Cronos Group by 119.0% in the third quarter. International Assets Investment Management LLC now owns 41,643 shares of the company’s stock valued at $91,000 after buying an additional 22,628 shares during the period. Finally, Headlands Technologies LLC raised its holdings in Cronos Group by 12,309.4% in the 2nd quarter. Headlands Technologies LLC now owns 27,797 shares of the company’s stock valued at $65,000 after buying an additional 27,573 shares during the last quarter. Institutional investors and hedge funds own 8.71% of the company’s stock.
Cronos Group Price Performance
CRON opened at $1.89 on Thursday. Cronos Group Inc. has a fifty-two week low of $1.86 and a fifty-two week high of $3.14. The company’s 50 day moving average price is $2.09 and its two-hundred day moving average price is $2.23. The firm has a market capitalization of $722.54 million, a price-to-earnings ratio of -14.54 and a beta of 0.99.
Cronos Group Profile
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
See Also
- Five stocks we like better than Cronos Group
- How to buy stock: A step-by-step guide for beginners
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What Does Downgrade Mean in Investing?
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Industrial Products Stocks Investing
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Want to see what other hedge funds are holding CRON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cronos Group Inc. (NASDAQ:CRON – Free Report).
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.